Equity News Results

  • US STOCKS-Wall St eyes subdued open as Caterpillar, Texas Instruments disappoint

    * Caterpillar (CAT) drops after lowering profit forecast. * Texas Instruments (TXN) leads declines among chip stocks. * Boston Scientific (BSX), Thermo Fisher rise on upbeat profits. * Futures: Dow flat, S&P 500 off 0.08%, Nasdaq up 0.07% By Shreyashi Sanyal and Arjun Panchadar.

  • GLOBAL MARKETS-Shares sapped by tech problems and Brexit snags

    * Brexit developments sap share rally, pound yanked off $1.30. * Texas Instruments (TXN) revenue forecast hits chipmakers. * China says report of HK's Lam being replaced has "ulterior motives" * Graphic: World FX rates in 2019 http://tmsnrt.rs/2egbfVh. * By Marc Jones.

  • GLOBAL MARKETS-Shares hit by tech problems and Brexit snags

    * Brexit developments sap rally in global shares, pound yanked off %1.30. * Texas Instruments (TXN) revenue forecast hits chipmakers. * China says report of HK's Carrie Lam being replaced has "ulterior motives" * Graphic: World FX rates in 2019 http://tmsnrt.rs/2egbfVh. * By Marc Jones.

  • PRECIOUS-Gold holds steady amid Brexit uncertainties; technical buying gives support

    * Markets focus on Fed talks on Oct. 29 and 30. * SPDR Gold Trust holdings fell 0.5% on Tuesday. By Diptendu Lahiri. Gold prices were largely unchanged on Wednesday, as investors awaited more clarity on the Brexit and the U.S.-China trade war, while some technical buying provided modest support to the bullion. Spot gold was up 0.1% at $1,489.31 per ounce as of 0622 GMT.

  • PRECIOUS-Gold bides time as traders await clarity on Brexit

    Gold prices were steady on Wednesday, as investors waited for clarity on Brexit confusion after UK lawmakers voted for Prime Minister Boris Johnson's divorce plan but opposed his tight timetable to complete the legislative process in three days. FUNDAMENTALS. * Spot gold was unchanged at $1,488.50 per ounce, as of 0125 GMT.

  • GLOBAL MARKETS-Asian shares struggle after yet another Brexit delay

    * Brexit delay saps rally in global shares. * Texas Instruments (TXN) earnings hit chipmakers. By Hideyuki Sano. Asian shares and U.S. stock futures dipped on Wednesday after British lawmakers rejected the government's timetable to fast-track legislation for its deal to take Britain out of the European Union.

  • US STOCKS-Wall Street slips after rejection of Brexit timetable

    * P&G, UTC gain after results; McDonald's (MCD), Travelers fall. * Facebook (FB) falls as probe into consumer data, advertising expands. * Biogen surges on plans to seek FDA approval for Alzheimer's drug. * Indexes down: Dow 0.15%, S&P 500 0.36%, Nasdaq 0.72% By April Joyner.

  • US STOCKS SNAPSHOT-Wall Street slips after Brexit vote

    U.S. stocks ended lower on Tuesday, giving up early gains after British lawmakers rejected the government's proposed timetable for passing legislation to ratify its deal to exit the European Union. The Dow Jones Industrial Average fell 38.66 points, or 0.14%, to 26,788.98, the S&P 500 lost 10.6 points, or 0.35%, to 2,996.12 and the Nasdaq Composite dropped 58.69 points, or 0.72%, to 8,104.30.

  • GLOBAL MARKETS-Pound, stocks slip; lawmakers reject Brexit law timetable

    * Sterling down. * U.S. stocks reverse earlier gains. * United States, China sound upbeat on trade talks. By Caroline Valetkevitch. Stocks on world markets declined, with the S&P 500 turning lower, and the pound weakened on Tuesday after British lawmakers rejected the government's proposed timetable for passing legislation to ratify a deal over Britain's exit from the European Union.

  • US STOCKS-Mixed earnings, failed Brexit vote push down S&P 500

    * P&G, UTC gain on raising full-year forecasts. * Facebook falls as probe into consumer data, advertising expands. * Biogen surges on plans to seek FDA approval for Alzheimer's drug. * Dow up 0.05%, S&P 500 down 0.18%, Nasdaq off 0.55% By April Joyner.

Search News

Filter Results

Publication Date
Topic
Provider

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.